Back

DSE Antibody 1 Publications

Rabbit Polyclonal| Catalog number: 10452-1-AP

  • Print page
  • Download PDF

Be the first to review this product

-_-

Freight/Packing

Con: 20 μg/150 μl

Choose size:

Please visit your regions distributor:

Request quote for
bulk/custom formulations

Special offer: Add control/tag antibody for $99
Load more

Tested Applications

Applications:
IHC, IF, ELISA
Application not tested? Please see our Guarantee


Images See all

DSE Antibody IHC human liver cancer tissue 10452-1-AP

Immunohistochemical of paraffin-embedded human liver cancer using 10452-1-AP(DSE antibody) at dilution of 1:50 (under 10x lens)

DSE Antibody IHC human liver cancer tissue 10452-1-AP

Immunohistochemical of paraffin-embedded human liver cancer using 10452-1-AP(DSE antibody) at dilution of 1:50 (under 40x lens)

Species specificity:
human
Positive IHC detected in:
human liver cancer tissue
Recommended dilution:
IHC : 1:20-1:200

Protocols

Product-specific protocols

Standard Protocols

Product Information

Source:
Rabbit
Purification method:
Antigen affinity purification
Isotype:
IgG
Storage:
PBS with 0.1% sodium azide and 50% glycerol pH 7.3. Store at -20oC. Aliquoting is unnecessary for -20oC storage.

Immunogen Information

Immunogen:
DSE fusion protein Ag0695
Full name:
dermatan sulfate epimerase
Calculated molecular weight:
958 aa,110 kDa
Observed molecular weight:
GenBank accession number:
BC039245
Gene ID (NCBI):
29940
Gene symbol
DSE
Synonyms
dermatan sulfate epimerase, DS epimerase, DSE, DSEPI, SART 2, SART2

Background

DSE, also named as SART2 and DSEPI, is an enzyme that converts D-glucuronic acid to L-iduronic acid residues in dermatan sulphate biosynthesis. It is also identified to be a tumour-associated antigen. DSE is recognized by cytotoxic T cells (CTLs) and its enhanced expression in many cancers has been reported. DSE is a potential candidate for a tumour antigen with immunogenicity.


Back
to top